| 1 | Acne Vulgaris | 42.7% |
| 2 | Rhinophyma | 42.7% |
| 3 | Acne | 42.7% |
| 4 | Pyoderma Gangrenosum | 40% |
| 5 | Lupus Erythematosus, Cutaneous | 32.9% |
| 6 | Panniculitis | 32.9% |
| 7 | Systemic Scleroderma | 32.9% |
| 8 | Morphea | 32.9% |
| 9 | Contact Dermatitis | 32% |
| 10 | Eczema | 32% |
| 11 | Erythema Multiforme | 32% |
| 12 | Intertrigo | 32% |
| 13 | Neurodermatitis | 32% |
| 14 | Perioral Dermatitis | 32% |
| 15 | Acne Conglobata | 31.6% |
| 16 | Xeroderma Pigmentosum | 31.1% |
| 17 | Breast Diseases | 30.5% |
| 18 | Dermatitis | 30.5% |
| 19 | Exanthema | 30.5% |
| 20 | Facial Dermatoses | 30.5% |
| 21 | Hair Diseases | 30.5% |
| 22 | Hand Dermatoses | 30.5% |
| 23 | keratoacanthoma | 30.5% |
| 24 | Keratosis | 30.5% |
| 25 | Nail Diseases | 30.5% |
| 26 | Photosensitivity Disorders | 30.5% |
| 27 | Prurigo | 30.5% |
| 28 | Pyoderma | 30.5% |
| 29 | Rosacea | 30.5% |
| 30 | Skin Diseases, Vesiculobullous | 30.5% |
| 31 | Skin Ulcer | 30.5% |
| 32 | Sweat Gland Diseases | 30.5% |
| 33 | Skin Diseases, Papulosquamous | 30.5% |
| 34 | Skin Diseases, Vascular | 30.5% |
| 35 | Acneiform Eruptions | 30.5% |
| 36 | Ocular Rosacea | 30.5% |
| 37 | Subcorneal pustular dermatosis | 30.5% |
| 38 | Erythematotelangiectatic Rosacea | 30.5% |
| 39 | Papulopustular Rosacea | 30.5% |
| 40 | Chronic Actinic Dermatitis | 30.5% |
| 41 | Dermatitis, Atopic | 30% |
| 42 | Epidermolysis Bullosa | 30% |
| 43 | Dermatitis, Phototoxic | 29.5% |
| 44 | Pityriasis Lichenoides et Varioliformis Acuta | 29.5% |
| 45 | Pityriasis Lichenoides | 29.5% |
| 46 | Phototoxicity | 29.5% |
| 47 | Foot Ulcer | 27.8% |
| 48 | Dermatitis Herpetiformis | 27% |
| 49 | Acrodermatitis | 26.7% |
| 50 | Porokeratosis | 26.7% |
| 51 | Gianotti-Crosti Syndrome | 26.7% |
| 52 | Keratoderma, Palmoplantar | 26.7% |
| 53 | Panniculitis, Lupus Erythematosus | 26.4% |
| 54 | Necrobiosis Lipoidica Diabeticorum | 25.6% |
| 55 | Foot Diseases | 25.4% |
| 56 | Dermatitis, Photoallergic | 25.2% |
| 57 | Skin Abnormalities | 24.7% |
| 58 | Skin Diseases, Infectious | 24.7% |
| 59 | Pigmentation Disorders | 24.7% |
| 60 | Lipomatosis | 24.3% |
| 61 | Pruritus | 24.3% |
| 62 | Erythema | 24.3% |
| 63 | Necrolytic Migratory Erythema | 24.3% |
| 64 | Cutaneous Fistula | 24.3% |
| 65 | Nephrogenic Fibrosing Dermopathy | 24.3% |
| 66 | Nephrogenic Systemic Fibrosis | 24.3% |
| 67 | Urticaria Pigmentosa | 24.2% |
| 68 | Dermatitis, Irritant | 23.7% |
| 69 | Erythema Induratum | 23.2% |
| 70 | Xeroderma | 23.1% |
| 71 | Dermatomyositis | 23% |
| 72 | Mastocytosis | 21.8% |
| 73 | Lupus Erythematosus, Discoid | 21.3% |
| 74 | Scleroderma, Limited | 21.3% |
| 75 | Acanthoma | 20.5% |
| 76 | Dermatitis, Occupational | 20.5% |
| 77 | Breast Cyst | 20.3% |
| 78 | Actinic keratosis | 20.3% |
| 79 | Cutis Laxa | 20.2% |
| 80 | Erythema Infectiosum | 20.1% |
| 81 | Pseudoxanthoma Elasticum | 20.1% |
| 82 | Anhidrosis | 20% |
| 83 | Cholesteatoma | 20% |
| 84 | Pressure Ulcer | 20% |
| 85 | Ectodermal Dysplasia | 20% |
| 86 | Exanthema Subitum | 20% |
| 87 | Folliculitis | 20% |
| 88 | Foot Dermatoses | 20% |
| 89 | Gynecomastia | 20% |
| 90 | Hypertrichosis | 20% |
| 91 | Hypohidrosis | 20% |
| 92 | Hypotrichosis | 20% |
| 93 | Leg Ulcer | 20% |
| 94 | Miliaria | 20% |
| 95 | Parakeratosis | 20% |
| 96 | Parapsoriasis | 20% |
| 97 | Pityriasis | 20% |
| 98 | Psoriasis | 20% |
| 99 | Sweet Syndrome | 20% |
| 100 | Hidradenitis | 20% |
| 101 | Onycholysis | 20% |
| 102 | Miliaria Rubra | 20% |
| 103 | Hyperpigmentation | 20% |
| 104 | Lichenoid Eruptions | 20% |
| 105 | Chloracne | 20% |
| 106 | Aplasia Cutis Congenita | 20% |
| 107 | Breast Neoplasms, Male | 19.9% |
| 108 | Triple Negative Breast Neoplasms | 19.9% |
| 109 | Dermatitis, Allergic Contact | 19.8% |
| 110 | Erythema Nodosum | 19.7% |
| 111 | Papillon-Lefevre Disease | 19.7% |
| 112 | Toxic Epidermal Necrolysis | 19.6% |
| 113 | Stevens-Johnson Syndrome | 19.6% |
| 114 | Diaper Rash | 19.6% |
| 115 | Tinea Capitis | 18.2% |
| 116 | Onychomycosis | 18.2% |
| 117 | Connective Tissue Diseases | 17.5% |
| 118 | Mastocytoma | 17.5% |
| 119 | Hyperkeratosis, Epidermolytic | 17.3% |
| 120 | Ecthyma | 17.3% |
| 121 | Carcinoma, Lobular | 16.6% |
| 122 | Granuloma Annulare | 16.6% |
| 123 | Ichthyosis, X-Linked | 16.4% |
| 124 | Sjogren-Larsson Syndrome | 16.3% |
| 125 | Acantholysis | 16.2% |
| 126 | Pemphigoid, Benign Mucous Membrane | 16.2% |
| 127 | Pemphigus | 16.2% |
| 128 | Piedra | 16.2% |
| 129 | Sunburn | 16.2% |
| 130 | Argyria | 16% |
| 131 | Hirsutism | 16% |
| 132 | Lactation Disorder | 16% |
| 133 | Mastitis | 16% |
| 134 | Urticaria | 16% |
| 135 | Adiposis Dolorosa | 15.9% |
| 136 | Pruritus Vulvae | 15.9% |
| 137 | Pruritus Ani | 15.8% |
| 138 | Behcet Syndrome | 15.5% |
| 139 | Abdominal Neoplasms | 15.3% |
| 140 | Head and Neck Neoplasms | 15.3% |
| 141 | Sebaceous Gland Diseases | 15.3% |
| 142 | Soft Tissue Neoplasms | 15.3% |
| 143 | Thoracic Neoplasms | 15.3% |
| 144 | Lichen Planus | 14.9% |
| 145 | Melanosis | 14.9% |
| 146 | Chloasma | 14.9% |
| 147 | Pityriasis Rosea | 14.9% |
| 148 | Pityriasis Rubra Pilaris | 14.9% |
| 149 | Vitiligo | 14.9% |
| 150 | Lichen Nitidus | 14.9% |
| 151 | Hidradenitis Suppurativa | 14.8% |
| 152 | Albinism | 14% |
| 153 | Erythema Chronicum Migrans | 13.7% |
| 154 | Dermatomycoses | 13.5% |
| 155 | Mucocutaneous Lymph Node Syndrome | 13.5% |
| 156 | Skin Diseases, Bacterial | 13.5% |
| 157 | Tinea Pedis | 13.4% |
| 158 | Drug Eruptions | 13.3% |
| 159 | Lipodystrophy | 13.3% |
| 160 | Sebaceous Gland Neoplasms | 13.3% |
| 161 | Livedo Reticularis | 13.3% |
| 162 | Malignant Atrophic Papulosis | 13.3% |
| 163 | Polyarteritis Nodosa | 13.2% |
| 164 | Takayasu Arteritis | 13.2% |
| 165 | Digestive System Neoplasms | 12.7% |
| 166 | Endocrine Gland Neoplasms | 12.7% |
| 167 | Eye Neoplasms | 12.7% |
| 168 | Nervous System Neoplasms | 12.7% |
| 169 | Acanthosis Nigricans | 12.3% |
| 170 | Alopecia Areata | 12.3% |
| 171 | Lentigo | 12.3% |
| 172 | Bone neoplasms | 12.3% |
| 173 | Skin Neoplasms | 12.3% |
| 174 | Hematologic Neoplasms | 12.3% |
| 175 | Splenic Neoplasms | 12.2% |
| 176 | Alopecia | 12.1% |
| 177 | Sweating, Gustatory | 12.1% |
| 178 | Androgenetic Alopecia | 12.1% |
| 179 | Auriculotemporal Syndrome | 12.1% |
| 180 | Lice Infestations | 11.9% |
| 181 | Varicose Ulcer | 11.9% |
| 182 | Galactorrhea | 11.8% |
| 183 | Mycetoma | 11.8% |
| 184 | Nail-Patella Syndrome | 11.7% |
| 185 | Parathyroid Neoplasms | 11.7% |
| 186 | Peritoneal Neoplasms | 11.7% |
| 187 | Thyroid Neoplasm | 11.7% |
| 188 | Thyroid carcinoma | 11.7% |
| 189 | Porphyrias, Hepatic | 11.5% |
| 190 | Multiple Endocrine Neoplasia | 10.3% |
| 191 | Pancreatic Neoplasm | 10.3% |
| 192 | Paraneoplastic Encephalomyelitis | 10.2% |
| 193 | Collagen Diseases | 10.2% |
| 194 | Mixed Connective Tissue Disease | 10.2% |
| 195 | Mucinoses | 10.2% |
| 196 | Tracheal Neoplasms | 10.1% |
| 197 | Larva Migrans | 10.1% |
| 198 | Leishmaniasis | 10.1% |
| 199 | Mammary Neoplasms, Experimental | 10.1% |
| 200 | Molluscum Contagiosum | 10.1% |
| 201 | Lichen Planus, Oral | 10% |
| 202 | Angioedema | 10% |
| 203 | Retroperitoneal Neoplasms | 10% |
| 204 | Onchocerciasis | 10% |
| 205 | Chromoblastomycosis | 9.9% |
| 206 | Dermatophytosis | 9.9% |
| 207 | Sporotrichosis | 9.9% |
| 208 | Tinea | 9.9% |
| 209 | Tinea Versicolor | 9.9% |
| 210 | Trichophytosis | 9.9% |
| 211 | Hyalohyphomycosis | 9.9% |
| 212 | Acute Generalized Exanthematous Pustulosis | 9.8% |
| 213 | Myxoid cyst | 9.5% |
| 214 | Peutz-Jeghers Syndrome | 9.3% |
| 215 | Hamartoma | 8.8% |
| 216 | Neoplasms, Hormone-Dependent | 8.8% |
| 217 | Neoplasms, Multiple Primary | 8.8% |
| 218 | Paraneoplastic Syndromes | 8.8% |
| 219 | Precancerous Conditions | 8.8% |
| 220 | Neoplasms, Second Primary | 8.8% |
| 221 | Esophageal Neoplasms | 8.7% |
| 222 | CREST Syndrome | 8.7% |
| 223 | Warts | 8.7% |
| 224 | Candidiasis, Chronic Mucocutaneous | 8.5% |
| 225 | Cutaneous Candidiasis | 8.5% |
| 226 | Thyroid Nodule | 8.5% |
| 227 | Cartilage Diseases | 8.5% |
| 228 | Erysipelas | 8.5% |
| 229 | Rheumatism | 8.5% |
| 230 | Serum Sickness | 8.5% |
| 231 | Staphylococcal Skin Infections | 8.5% |
| 232 | Chondromalacia | 8.5% |
| 233 | Variegate Porphyria | 8.5% |
| 234 | Acute intermittent porphyria | 8.5% |
| 235 | Porphyria Cutanea Tarda | 8.5% |
| 236 | Erythrasma | 8.4% |
| 237 | Arthritis, Psoriatic | 8.4% |
| 238 | Leishmaniasis, Cutaneous | 8.2% |
| 239 | Lupus Erythematosus, Systemic | 8.2% |
| 240 | Overlap syndrome | 8.2% |
| 241 | Eczema Herpeticum | 8.2% |
| 242 | Fusariosis | 8.2% |
| 243 | Mouth Neoplasms | 8.1% |
| 244 | Central Nervous System Neoplasms | 8.1% |
| 245 | Vascular Neoplasms | 8.1% |
| 246 | Thymus Neoplasms | 8.1% |
| 247 | Genital Neoplasms, Female | 8% |
| 248 | Dupuytren Contracture | 7.9% |
| 249 | Giant Cell Arteritis | 7.9% |
| 250 | Temporal Arteritis | 7.9% |
| 251 | Testicular Neoplasms | 7.8% |
| 252 | Carcinoma, Pancreatic Ductal | 7.5% |
| 253 | Hereditary Angioedema Type III | 7.3% |
| 254 | Hereditary Angioedema Types I and II | 7.3% |
| 255 | Meningioma | 7.3% |
| 256 | Thymoma | 7.2% |
| 257 | Angioedemas, Hereditary | 7.1% |
| 258 | Epidermodysplasia Verruciformis | 7.1% |
| 259 | Herpes Labialis | 7.1% |
| 260 | Cyst | 7% |
| 261 | Neoplastic Processes | 7% |
| 262 | Neoplastic Syndromes, Hereditary | 7% |
| 263 | Pregnancy Complications, Neoplastic | 7% |
| 264 | Diabetic Foot | 7% |
| 265 | Multiple Endocrine Neoplasia Type 1 | 7% |
| 266 | Staphylococcal Scalded Skin Syndrome | 7% |
| 267 | Neoplasms, Experimental | 6.9% |
| 268 | Adrenal Gland Neoplasms | 6.8% |
| 269 | Gastrointestinal Neoplasms | 6.8% |
| 270 | Genital Neoplasms, Male | 6.8% |
| 271 | Liver neoplasms | 6.8% |
| 272 | Uveal Neoplasms | 6.8% |
| 273 | Urologic Neoplasms | 6.7% |
| 274 | Spinal Neoplasms | 6.7% |
| 275 | Scleromyxedema | 6.7% |
| 276 | Bone Marrow Neoplasms | 6.7% |
| 277 | Blastomycosis | 6.6% |
| 278 | HIV-Associated Lipodystrophy Syndrome | 6.5% |
| 279 | Carcinoma 256, Walker | 6.4% |
| 280 | Acoustic Neuroma | 6.3% |
| 281 | insulinoma | 6.3% |
| 282 | Vipoma | 6.3% |
| 283 | Liver Neoplasms, Experimental | 6.2% |
| 284 | carbuncle | 6.2% |
| 285 | Gastrinoma | 6.2% |
| 286 | Glucagonoma | 6.2% |
| 287 | Condylomata Acuminata | 6.2% |
| 288 | Leukoplakia, Oral | 6.2% |
| 289 | Furunculosis | 6.2% |
| 290 | furuncle | 6.2% |
| 291 | Paraneoplastic Cerebellar Degeneration | 6.1% |
| 292 | Nose Neoplasms | 6.1% |
| 293 | Impetigo | 6.1% |
| 294 | Rhinoscleroma | 6.1% |
| 295 | Carcinoma, Ehrlich Tumor | 6% |
| 296 | Dermoid Cyst | 6% |
| 297 | Carcinoma, Lewis Lung | 6% |
| 298 | Palatal Neoplasms | 6% |
| 299 | Menkes Kinky Hair Syndrome | 6% |
| 300 | Meningeal Neoplasms | 6% |
| 301 | Neoplasms, Radiation-Induced | 5.8% |
| 302 | Cellulitis | 5.7% |
| 303 | Hepatocellular Adenoma | 5.7% |
| 304 | Trophoblastic Neoplasms | 5.6% |
| 305 | Retinoblastoma | 5.6% |
| 306 | Leukemia, Experimental | 5.6% |
| 307 | Melanoma, Experimental | 5.5% |
| 308 | Pituitary Adenoma | 5.5% |
| 309 | Pituitary Neoplasms | 5.5% |
| 310 | Neoplasms, Neuroepithelial | 5.5% |
| 311 | Gliomatosis cerebri | 5.5% |
| 312 | Mesenteric Panniculitis | 5.4% |
| 313 | Panniculitis, Peritoneal | 5.4% |
| 314 | Tietze's Syndrome | 5.4% |
| 315 | Orbital Cellulitis | 5.4% |
| 316 | Leydig Cell Tumor | 5.4% |
| 317 | Limbic Encephalitis | 5.3% |
| 318 | Myxedema | 5.3% |
| 319 | Neuroectodermal Tumors | 5.3% |
| 320 | Optic Nerve Glioma | 5.3% |
| 321 | Nephroblastoma | 5.2% |
| 322 | Ear Neoplasms | 5.1% |
| 323 | Erythroplasia | 5.1% |
| 324 | Eyelid Neoplasms | 5.1% |
| 325 | Follicular cyst | 5.1% |
| 326 | leukemia | 5.1% |
| 327 | Lung Neoplasms | 5.1% |
| 328 | Mucocele | 5.1% |
| 329 | Neoplasms, Germ Cell and Embryonal | 5.1% |
| 330 | Neoplasms, Glandular and Epithelial | 5.1% |
| 331 | Pilonidal Cyst | 5.1% |
| 332 | Pleural Neoplasms | 5.1% |
| 333 | Thyroglossal Cyst | 5.1% |
| 334 | Synovial Cyst | 5.1% |
| 335 | Germ Cell Cancer | 5.1% |
| 336 | Aberrant Crypt Foci | 5.1% |
| 337 | Tuberous Sclerosis | 5.1% |
| 338 | Medulloblastoma | 5% |
| 339 | Sarcoma, Experimental | 5% |
| 340 | ovarian neoplasm | 5% |
| 341 | Brain Neoplasms | 5% |
| 342 | Salivary Gland Neoplasms | 5% |
| 343 | Spinal Cord Neoplasms | 5% |
| 344 | Tongue Neoplasms | 5% |
| 345 | Prolactinoma | 4.9% |
| 346 | Growth Hormone-Secreting Pituitary Adenoma | 4.9% |
| 347 | melanoma | 4.9% |
| 348 | Uterine Neoplasms | 4.9% |
| 349 | Vaginal Neoplasms | 4.9% |
| 350 | Vulvar Neoplasms | 4.9% |
| 351 | Uterine Cancer | 4.9% |
| 352 | Meningeal Carcinomatosis | 4.9% |
| 353 | Fallopian Tube Neoplasms | 4.9% |
| 354 | Lambert-Eaton Myasthenic Syndrome | 4.8% |
| 355 | Leukemia, Radiation-Induced | 4.8% |
| 356 | Carcinosarcoma | 4.6% |
| 357 | Hemangiosarcoma | 4.6% |
| 358 | Leukemia L1210 | 4.6% |
| 359 | Leukemia P388 | 4.6% |
| 360 | lymphangiosarcoma | 4.6% |
| 361 | Osteochondritis | 4.5% |
| 362 | Polymyalgia Rheumatica | 4.5% |
| 363 | Osteogenesis Imperfecta | 4.5% |
| 364 | Choriocarcinoma | 4.4% |
| 365 | Noonan Syndrome | 4.4% |
| 366 | Keloid | 4.4% |
| 367 | Pharyngeal Neoplasms | 4.4% |
| 368 | Adenoma, Acidophil | 4.3% |
| 369 | Ganglioneuroma | 4.3% |
| 370 | Glioma | 4.3% |
| 371 | Malignant Glioma | 4.3% |
| 372 | granulosa cell tumor | 4.3% |
| 373 | Carcinoma, Ovarian Epithelial | 4.3% |
| 374 | Opsoclonus-Myoclonus Syndrome | 4.3% |
| 375 | Central Nervous System Cysts | 4.3% |
| 376 | Sarcoma 180 | 4.3% |
| 377 | Bile Duct Neoplasms | 4.3% |
| 378 | gallbladder neoplasm | 4.3% |
| 379 | Intestinal Neoplasms | 4.3% |
| 380 | Penile Neoplasms | 4.3% |
| 381 | Prostatic Neoplasms | 4.3% |
| 382 | Stomach Neoplasms | 4.3% |
| 383 | Polycythemia Vera | 4.2% |
| 384 | Bronchial Neoplasms | 4.2% |
| 385 | Mesoblastic Nephroma | 4.2% |
| 386 | Adenomatous Polyposis Coli | 4.1% |
| 387 | Multiple Pulmonary Nodules | 4.1% |
| 388 | Leukoplakia | 4.1% |
| 389 | Lymphocele | 4.1% |
| 390 | Pancreatic Cyst | 4.1% |
| 391 | Supratentorial Neoplasms | 4.1% |
| 392 | Carcinoid Tumor | 4.1% |
| 393 | Endometrial Neoplasms | 4.1% |
| 394 | Neurilemmoma | 4.1% |
| 395 | Hutchinson's Melanotic Freckle | 4.1% |
| 396 | Adrenocortical carcinoma | 4.1% |
| 397 | Melanoma, Amelanotic | 4.1% |
| 398 | Barrett Esophagus | 4.1% |
| 399 | Histiocytic Disorders, Malignant | 4.1% |
| 400 | Mediastinal Cyst | 4.1% |
| 401 | Neoplasm Invasiveness | 4.1% |
| 402 | Neoplasm Metastasis | 4.1% |
| 403 | Neoplasm Recurrence, Local | 4.1% |
| 404 | Parovarian Cyst | 4.1% |
| 405 | Pericardial Cyst | 4.1% |
| 406 | Thymic Cyst | 4.1% |
| 407 | Carcinogenesis | 4.1% |
| 408 | Metastasis | 4.1% |
| 409 | Marfan Syndrome | 4% |
| 410 | Lymphomatoid Granulomatosis | 4% |
| 411 | Basal cell carcinoma | 3.9% |
| 412 | Carcinoma, Papillary | 3.9% |
| 413 | Squamous cell carcinoma | 3.9% |
| 414 | Chondrosarcoma | 3.9% |
| 415 | Craniopharyngioma | 3.9% |
| 416 | Cystadenoma | 3.9% |
| 417 | leiomyosarcoma | 3.9% |
| 418 | liposarcoma | 3.9% |
| 419 | Mesothelioma | 3.9% |
| 420 | synovial sarcoma | 3.9% |
| 421 | Neuroectodermal Tumor, Melanotic | 3.9% |
| 422 | Angiomyolipoma | 3.9% |
| 423 | Clear Cell Sarcoma of Soft Tissue | 3.9% |
| 424 | Alveolar Soft Part Sarcoma | 3.9% |
| 425 | Neuroendocrine Tumors | 3.9% |
| 426 | Sarcoma, Myeloid | 3.9% |
| 427 | Carcinoma, Basal Cell | 3.9% |
| 428 | Homocystinuria | 3.9% |
| 429 | Myelitis, Transverse | 3.9% |
| 430 | Rheumatoid Arthritis | 3.9% |
| 431 | Juvenile arthritis | 3.9% |
| 432 | Laryngeal neoplasm | 3.9% |
| 433 | Leukemia, Plasma Cell | 3.8% |
| 434 | Astrocytoma | 3.8% |
| 435 | Ependymoma | 3.8% |
| 436 | oligodendroglioma | 3.8% |
| 437 | Ganglioglioma | 3.8% |
| 438 | gliosarcoma | 3.8% |
| 439 | Anaplastic astrocytoma | 3.8% |
| 440 | Anaplastic Oligodendroglioma | 3.8% |
| 441 | Composite Lymphoma | 3.8% |
| 442 | Lupus Nephritis | 3.8% |
| 443 | Basal Cell Nevus Syndrome | 3.7% |
| 444 | Bladder Neoplasm | 3.7% |
| 445 | Kidney Neoplasm | 3.7% |
| 446 | Ureteral Neoplasms | 3.7% |
| 447 | Urethral Neoplasms | 3.7% |
| 448 | Brain Stem Neoplasms | 3.7% |
| 449 | Malignant Carcinoid Syndrome | 3.6% |
| 450 | Cystadenocarcinoma | 3.6% |
| 451 | Fibrosarcoma | 3.6% |
| 452 | Osteosarcoma | 3.6% |
| 453 | Mucoepidermoid Carcinoma | 3.6% |
| 454 | Renal Cell Carcinoma | 3.6% |
| 455 | Papillary Renal Cell Carcinoma | 3.6% |
| 456 | Hypopharyngeal Neoplasms | 3.5% |
| 457 | Pleural Effusion, Malignant | 3.5% |
| 458 | Hypopharyngeal Cancer | 3.5% |
| 459 | Glioblastoma | 3.5% |
| 460 | Neuroblastoma | 3.5% |
| 461 | Glioblastoma Multiforme | 3.5% |
| 462 | Parotid Neoplasms | 3.5% |
| 463 | Prostatic Neoplasms, Castration-Resistant | 3.5% |
| 464 | Nelson Syndrome | 3.5% |
| 465 | Choroid Plexus Papilloma | 3.4% |
| 466 | Adenofibroma | 3.4% |
| 467 | Fibroadenoma | 3.4% |
| 468 | Malignant Fibrous Histiocytoma | 3.4% |
| 469 | Laryngomalacia | 3.4% |
| 470 | Pectus carinatum | 3.4% |
| 471 | Lymphoma | 3.4% |
| 472 | Ganglioneuroblastoma | 3.4% |
| 473 | Corpus Luteum Cyst | 3.3% |
| 474 | Ovarian Cysts | 3.3% |
| 475 | Adenoma | 3.3% |
| 476 | Ameloblastoma | 3.3% |
| 477 | Angiokeratoma | 3.3% |
| 478 | Carcinoma | 3.3% |
| 479 | Chordoma | 3.3% |
| 480 | Hemangioma | 3.3% |
| 481 | hemangiopericytoma | 3.3% |
| 482 | Lymphangioma | 3.3% |
| 483 | Mesenchymoma | 3.3% |
| 484 | Nevus | 3.3% |
| 485 | Teratoma | 3.3% |
| 486 | Hepatoblastoma | 3.3% |
| 487 | Mixed Tumor, Mullerian | 3.3% |
| 488 | Germinoma | 3.3% |
| 489 | Teratocarcinoma | 3.3% |
| 490 | Angiofibroma | 3.3% |
| 491 | Sarcoma | 3.3% |
| 492 | Epithelioma | 3.3% |
| 493 | Carcinoma, Endometrioid | 3.3% |
| 494 | Rheumatoid Nodule | 3.3% |
| 495 | Bowen's Disease | 3.3% |
| 496 | Paraganglioma | 3.3% |
| 497 | Rhabdomyosarcoma | 3.3% |
| 498 | Giant Cell Tumor of Bone | 3.3% |
| 499 | Nasopharyngeal carcinoma | 3.2% |
| 500 | Tonsillar Neoplasms | 3.1% |
| 501 | Cerebellar Neoplasms | 3.1% |
| 502 | Dermatofibrosarcoma | 3.1% |
| 503 | Dermatofibrosarcoma Protuberans | 3.1% |
| 504 | Cecal Neoplasms | 3.1% |
| 505 | Duodenal Neoplasms | 3.1% |
| 506 | Endometrial Stromal Sarcoma | 3% |
| 507 | Hydatidiform Mole | 3% |
| 508 | Carcinoid Heart Disease | 3% |
| 509 | Denys-Drash Syndrome | 3% |
| 510 | Pheochromocytoma | 2.9% |
| 511 | Alveolar rhabdomyosarcoma | 2.9% |
| 512 | Neurofibrosarcoma | 2.9% |
| 513 | Choledochal Cyst | 2.9% |
| 514 | Felty Syndrome | 2.8% |
| 515 | Bronchomalacia | 2.8% |
| 516 | Tracheomalacia | 2.8% |
| 517 | Lymphangioleiomyomatosis | 2.8% |
| 518 | Nasopharyngeal Neoplasms | 2.8% |
| 519 | Appendiceal Neoplasms | 2.7% |
| 520 | Colonic Neoplasms | 2.7% |
| 521 | Rectal Neoplasms | 2.7% |
| 522 | Colorectal Neoplasms | 2.7% |
| 523 | Pancreatic Pseudocyst | 2.7% |
| 524 | Plasmacytoma | 2.7% |
| 525 | Malignant histiocytosis | 2.6% |
| 526 | Lymphatic Metastasis | 2.6% |
| 527 | Neoplasms, Unknown Primary | 2.6% |
| 528 | Leukemic Infiltration | 2.6% |
| 529 | Histiocytic sarcoma | 2.6% |
| 530 | Neoplasm Micrometastasis | 2.6% |
| 531 | Paranasal Sinus Neoplasms | 2.5% |
| 532 | Adenocarcinoma | 2.5% |
| 533 | Carcinoma in Situ | 2.5% |
| 534 | Carcinoma, Transitional Cell | 2.5% |
| 535 | Phyllodes Tumor | 2.5% |
| 536 | Dysgerminoma | 2.5% |
| 537 | Hemangioendothelioma | 2.5% |
| 538 | Lipoma | 2.5% |
| 539 | Myoma | 2.5% |
| 540 | Myxoma | 2.5% |
| 541 | Neuroma | 2.5% |
| 542 | Papilloma | 2.5% |
| 543 | Pseudomyxoma Peritonei | 2.5% |
| 544 | Seminoma | 2.5% |
| 545 | Papillomatosis | 2.5% |
| 546 | Angiolipoma | 2.5% |
| 547 | Myelolipoma | 2.5% |
| 548 | Neoplasms, Bone Tissue | 2.5% |
| 549 | Neoplasms, Fibrous Tissue | 2.5% |
| 550 | Smooth Muscle Tumor | 2.5% |
| 551 | Adenomatosis, Pulmonary | 2.5% |
| 552 | Adenomatous Polyps | 2.5% |
| 553 | Carcinoma, Large Cell | 2.5% |
| 554 | Carcinoma, Small Cell | 2.5% |
| 555 | Desmoplastic Small Round Cell Tumor | 2.5% |
| 556 | Chondroma | 2.5% |
| 557 | Enchondroma | 2.5% |
| 558 | Rheumatoid Vasculitis | 2.5% |
| 559 | Mucopolysaccharidosis III | 2.4% |
| 560 | Anus Neoplasms | 2.3% |
| 561 | Sigmoid Neoplasms | 2.3% |
| 562 | Hodgkin Disease | 2.2% |
| 563 | Lymphoma, Non-Hodgkin | 2.2% |
| 564 | Sicca Syndrome | 2.2% |
| 565 | Sjogren's Syndrome | 2.2% |
| 566 | Maxillary Sinus Neoplasms | 2.2% |
| 567 | Polycystic Ovary Syndrome | 2.2% |
| 568 | Adenoid Cystic Carcinoma | 2.1% |
| 569 | fibroma | 2.1% |
| 570 | Fibromatosis | 2.1% |
| 571 | Osteoblastoma | 2.1% |
| 572 | Osteoma | 2.1% |
| 573 | Rhabdomyoma | 2.1% |
| 574 | Chondromatosis | 2.1% |
| 575 | Adenocarcinoma, Clear Cell | 2.1% |
| 576 | Cholangiocarcinoma | 2.1% |
| 577 | Cervical Intraepithelial Neoplasia | 2.1% |
| 578 | Hemangioblastoma | 2.1% |
| 579 | Lymphoma, Extranodal NK-T-Cell | 2.1% |
| 580 | Leukemia, Myelomonocytic, Chronic | 2% |
| 581 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2% |
| 582 | Primary amyloidosis | 1.9% |
| 583 | Lupus Vasculitis, Central Nervous System | 1.9% |
| 584 | Fibromatosis, Aggressive | 1.8% |
| 585 | Fibromatosis, Abdominal | 1.8% |
| 586 | Klatskin Tumor | 1.8% |
| 587 | Mucopolysaccharidosis II | 1.8% |
| 588 | Sturge-Weber Syndrome | 1.7% |
| 589 | Cell Transformation, Viral | 1.7% |
| 590 | Gastrointestinal Stromal Tumors | 1.7% |
| 591 | Hemangioma, Cavernous | 1.6% |
| 592 | Leukemia, T-Cell | 1.6% |
| 593 | Mastocytosis, Systemic | 1.6% |
| 594 | Leukemia, B-Cell | 1.6% |
| 595 | neurofibroma | 1.6% |
| 596 | Leukemia, Myeloid, Chronic-Phase | 1.6% |
| 597 | Lymphoma, Follicular | 1.6% |
| 598 | T-Cell Lymphoma | 1.6% |
| 599 | Mantle cell lymphoma | 1.6% |
| 600 | Waldenstrom Macroglobulinemia | 1.5% |
| 601 | Multiple Myeloma | 1.5% |
| 602 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.4% |
| 603 | Leukemia, Large Granular Lymphocytic | 1.4% |
| 604 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.4% |
| 605 | Lymphoma, T-Cell, Cutaneous | 1.4% |
| 606 | Lymphoma, AIDS-Related | 1.4% |
| 607 | Enteropathy-Associated T-Cell Lymphoma | 1.4% |
| 608 | Primary Effusion Lymphoma | 1.4% |
| 609 | Zollinger-Ellison syndrome | 1.3% |
| 610 | Mycosis Fungoides | 1.2% |
| 611 | Lymphomatoid Papulosis | 1.2% |
| 612 | Plasmablastic lymphoma | 1.2% |
| 613 | Burkitt Lymphoma | 1% |
| 614 | Sezary Syndrome | 0.9% |
| 615 | Radicular Cyst | 0.9% |